Home Cart 0 Sign in  
X

[ CAS No. 519032-08-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 519032-08-7
Chemical Structure| 519032-08-7
Chemical Structure| 519032-08-7
Structure of 519032-08-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 519032-08-7 ]

Related Doc. of [ 519032-08-7 ]

Alternatived Products of [ 519032-08-7 ]

Product Details of [ 519032-08-7 ]

CAS No. :519032-08-7 MDL No. :MFCD12026362
Formula : C17H19N3O6 Boiling Point : -
Linear Structure Formula :- InChI Key :NIVUTAZNLHLBAN-UHFFFAOYSA-N
M.W : 361.35 Pubchem ID :135446261
Synonyms :

Calculated chemistry of [ 519032-08-7 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.29
Num. rotatable bonds : 8
Num. H-bond acceptors : 8.0
Num. H-bond donors : 3.0
Molar Refractivity : 90.4
TPSA : 130.87 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.75
Log Po/w (XLOGP3) : 2.2
Log Po/w (WLOGP) : 1.58
Log Po/w (MLOGP) : 0.52
Log Po/w (SILICOS-IT) : 1.26
Consensus Log Po/w : 1.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.28
Solubility : 0.19 mg/ml ; 0.000525 mol/l
Class : Soluble
Log S (Ali) : -4.58
Solubility : 0.00945 mg/ml ; 0.0000262 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.02
Solubility : 0.0347 mg/ml ; 0.0000959 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.32

Safety of [ 519032-08-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 519032-08-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 519032-08-7 ]
  • Downstream synthetic route of [ 519032-08-7 ]

[ 519032-08-7 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 518047-98-8 ]
  • [ 762-42-5 ]
  • [ 519032-08-7 ]
YieldReaction ConditionsOperation in experiment
58%
Stage #1: at 20℃; for 2 h;
Stage #2: With xylene In methanol at 90 - 120℃; for 16 h; Inert atmosphere
Benzyl 2-amino-2-(hydroxyimino)-1,1-dimethylethylcarbamate (2.0 g, 8.0 mmol) was dissolved in 30 mL MeOH, dimethyl acetylenedicarboxylate (DMAD, 1.1 mL, 9.0 mmol) was added slowly. The mixture was stirred for 2 h at room temperature, and then concentrated under reduced pressure to give a white oil. The mixture of the oil and 80 mL xylene was stirred at 90 °C for 2 h and 120 °C for 2 h, then refluxed for 12 h under nitrogen, concentrated to yield the crude product. The crude product was recrystallized with 2 mL MeOH and 10 mL tert-butyl methyl ether to afford 5 as a yellow solid (1.7 g, 58 percent): 1H-NMR (DMSO-d6) δ: 7.35 (m, 5H), 5.00 (s, 2H), 3.83 (s, 3H), 1.48 (s, 6H); ESI-MS m/z 360 (M), 384 (M+Na) +.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 23, p. 7114 - 7118
  • 2
  • [ 100134-82-5 ]
  • [ 519032-08-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2225 - 2239
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 23, p. 7114 - 7118
  • 3
  • [ 501-53-1 ]
  • [ 519032-08-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2225 - 2239
  • 4
  • [ 1064707-10-3 ]
  • [ 519032-08-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 18, p. 5843 - 5855
  • 5
  • [ 1064707-10-3 ]
  • [ 519032-08-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2225 - 2239
  • 6
  • [ 518047-98-8 ]
  • [ 519032-08-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2225 - 2239
  • 7
  • [ 519032-08-7 ]
  • [ 140-75-0 ]
  • [ 519028-33-2 ]
YieldReaction ConditionsOperation in experiment
98% With triethylamine In methanol at 65 - 68℃; for 7 h; A round bottom flask was charged with methyl 2-(l-[(benzyloxy)carbonyl]amino}-l-methylethyl)-5,6-dihydroxypyrimidine-4-carboxylate (Compound I; 1 eq.) and methanol (-1.6 mL per gram of Compound 1). The slurry was warmed to 55°C, after which triethylamine (1.2 eqs.) was added in one portion. The solution was then warmed to 65°C and 4-fluorobenzylamine (1.2 eqs) was added at 65-68°C. The mixture was then aged at reflux for 7 hours. The solution was cooled to 550C5 and acetic acid (2 eqs.) was added in one portion. Water was added followed by seed crystals of 2. (Note: Crystallization would occur without seed, but seeding provides a more reliable method of crystal growth.) The resultant slurry was aged at 6O0C with the addition of more water during the ageing. The slurry was then cooled to 2O0C5 filtered, washed with 1 : 1 methanol:water, and dried in a nitrogen stream to give compound 2 (96 wt.percent purity by HPLC assay, 1.75 wt.percent water by Karl Fisher titration), 98percent overall yield (corrected for purity). Compound 2: lH NMR (600.13 MHz, CDCI3) δ 12.37 (br s, 2H), 7.95 (br t, J~6 Hz, IH), 735-7.31 (m, 2H)57.25-7.19 ( br m, 5H), 7.08-7.04 (m, 2H), 6.49 (s, IH)5 4.96 (s, 2H)5 4.58 (d, 3=6.0 Hz, 2H)5 1.64 (s, 6H).13C NMR (150.92 MHz, CDCI3) δ 168.5, 162.6 (d, JcF=246.6 Hz), 160.O5 155.35 154.1, 147.9, 136.5, 133.1 (d, JCF=3-1 Hz), 129.7 (d, JCF^7.9 Hz), 128.6, 128.1, 127.9, 127.1, 116.0 (d5 JCF=22.0 Hz), 66.8, 55.5, 42.7, 26.7.
Reference: [1] Patent: WO2009/88729, 2009, A1, . Location in patent: Page/Page column 44
[2] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2225 - 2239
[3] Journal of Medicinal Chemistry, 2006, vol. 49, # 23, p. 6646 - 6649
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 519032-08-7 ]

Aryls

Chemical Structure| 62222-38-2

[ 62222-38-2 ]

5,6-Dihydroxy-2-phenylpyrimidine-4-carboxylic acid

Similarity: 0.72

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 519028-33-2

[ 519028-33-2 ]

Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 1377049-84-7

[ 1377049-84-7 ]

Methyl ((2S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((2R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 518048-02-7

[ 518048-02-7 ]

Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate

Similarity: 0.53

Alcohols

Chemical Structure| 62222-38-2

[ 62222-38-2 ]

5,6-Dihydroxy-2-phenylpyrimidine-4-carboxylic acid

Similarity: 0.72

Chemical Structure| 878158-18-0

[ 878158-18-0 ]

Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate

Similarity: 0.68

Chemical Structure| 858956-25-9

[ 858956-25-9 ]

2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid

Similarity: 0.58

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 1256791-78-2

[ 1256791-78-2 ]

Methyl 5-hydroxy-6-methoxypicolinate

Similarity: 0.57

Amides

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 519028-33-2

[ 519028-33-2 ]

Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 1377049-84-7

[ 1377049-84-7 ]

Methyl ((2S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((2R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 1206524-85-7

[ 1206524-85-7 ]

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

Similarity: 0.53

Chemical Structure| 518048-02-7

[ 518048-02-7 ]

Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate

Similarity: 0.53

Esters

Chemical Structure| 878158-18-0

[ 878158-18-0 ]

Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate

Similarity: 0.68

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 1256791-78-2

[ 1256791-78-2 ]

Methyl 5-hydroxy-6-methoxypicolinate

Similarity: 0.57

Chemical Structure| 1260883-63-3

[ 1260883-63-3 ]

Methyl 5,6-dihydroxypicolinate

Similarity: 0.55

Chemical Structure| 5965-59-3

[ 5965-59-3 ]

Methyl 4-hydroxyquinoline-2-carboxylate

Similarity: 0.54

Amines

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 519028-33-2

[ 519028-33-2 ]

Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 1377049-84-7

[ 1377049-84-7 ]

Methyl ((2S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((2R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate

Similarity: 0.54

Chemical Structure| 518048-02-7

[ 518048-02-7 ]

Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate

Similarity: 0.53

Chemical Structure| 894803-87-3

[ 894803-87-3 ]

Methyl 4-amino-6-ethoxypicolinate

Similarity: 0.53

Related Parent Nucleus of
[ 519032-08-7 ]

Pyrimidines

Chemical Structure| 62222-38-2

[ 62222-38-2 ]

5,6-Dihydroxy-2-phenylpyrimidine-4-carboxylic acid

Similarity: 0.72

Chemical Structure| 878158-18-0

[ 878158-18-0 ]

Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate

Similarity: 0.68

Chemical Structure| 858956-25-9

[ 858956-25-9 ]

2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid

Similarity: 0.58

Chemical Structure| 888504-27-6

[ 888504-27-6 ]

Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Similarity: 0.57

Chemical Structure| 519028-33-2

[ 519028-33-2 ]

Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate

Similarity: 0.54